Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders ...

Cedar Grove Capital Management, an investment management company, released its first quarter 2025 investor letter. A copy of ...

One rising WWE star is rapidly being replacing Brock Lesnar as the company’s most explosive ever star in the minds of fans.

There are 4 femtosecond laser cataract surgery platforms currently available: Catalys, LenSx, LensAR (LensAR Inc.), and Victus. Elements of these platforms continue to evolve as more experience ...

Eye care company Alcon Inc., which has a major presence in North Texas, plans to buy Lensar Inc. in a deal valued up to $430 million. Orlando-based Lensar (Nasdaq: LNSR) is a laser cataract ...

— We have everything you need: full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; ...

--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and LENSAR, Inc. (NASDAQ: LNSR), a global medical technology company focused on ...

LENSAR has a 1 year low of $2.67 and a 1 year high of $17.31. Get LENSAR alerts: LENSAR (NASDAQ:LNSR – Get Free Report) last announced its quarterly earnings results on Thursday, February 27th.

Lake Street analyst Frank Takkinen downgraded Lensar (LNSR) to Hold from Buy with a price target of $15, down from $16, after Alcon (ALC) announced the acquisition of Lensar for $14.00 per share ...

Per the terms of the agreement, Alcon will purchase all outstanding shares of LENSAR for $14.00 per share in cash, with an additional non-tradeable contingent value right offering up to $2.75 per ...